Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide for Hemophagocytic Lymphohistiocytosis.

Allogeneic hematopoietic stem cell transplant (HSCT) has been known to be a curative therapy for patients with hemophagocytic lymphohistiocytosis (HLH) but donor availability is an issue. Haploidentical HSCT with posttransplant cyclophosphamide (PTCy) has been investigated as a feasible option for various malignant and nonmalignant conditions with reduced incidence of acute graft versus host disease (GVHD) and graft rejection. However, its use has not been described in children with HLH and here we describe 2 boys who underwent successful haploidentical HSCT with PTCy. None had acute GVHD and 1 had limited chronic GVHD. Both are alive and disease-free at follow-up of 912 and 239 days, respectively. Haploidentical HSCT with PTCy is a feasible option for children with HLH lacking a matched sibling donor.

[1]  M. Kharfan-Dabaja,et al.  Haploidentical transplantation as a promising therapy for relapsed hemophagocytic lymphohistiocytosis in an older adult patient. , 2016, Hematology/oncology and stem cell therapy.

[2]  M. Martelli,et al.  Haploidentical transplants using ex vivo T-cell depletion. , 2016, Seminars in hematology.

[3]  Jia Zhang,et al.  Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis , 2016, International Journal of Hematology.

[4]  Liang-ding Hu,et al.  Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. , 2014, Blood.

[5]  A. Sachdeva,et al.  Hemophagocytic Lymphohistiocytosis in Infants: A Single Center Experience from India , 2014, Pediatric hematology and oncology.

[6]  A. Filipovich,et al.  Reduced‐intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward , 2011, British journal of haematology.

[7]  O. Ohara,et al.  Hematopoietic stem cell transplantation with reduced intensity conditioning from a family haploidentical donor in an infant with familial hemophagocytic lymphohistocytosis , 2011, International journal of hematology.

[8]  S. Davies,et al.  Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. , 2010, Blood.

[9]  Allen R. Chen,et al.  High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. , 2010, Blood.

[10]  L. Luznik,et al.  High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation , 2010, Immunologic research.

[11]  A. Fischer,et al.  Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis: A Single-Center Report of 48 Patients , 2006, Pediatrics.

[12]  P. Veys,et al.  Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. , 2006, Blood.